Today: 30 April 2026
NuScale Power stock swings as new chemical-plant study puts SMR heat back in focus
12 January 2026
2 mins read

NuScale Power stock swings as new chemical-plant study puts SMR heat back in focus

NEW YORK, Jan 12, 2026, 12:06 PM EST — Regular session

  • NuScale Power shares retreat roughly 0.6% by midday, slipping after an initial rise
  • A company-backed study is focusing on chemical plants that require both steam and power
  • Investors are tuned in for insights from management at conferences scheduled this week

NuScale Power Corp shares slipped in midday trading Monday following the release of a study on using its small modular reactors to provide steam and electricity to chemical plants. “NuScale continues to lead … to provide process heat and electricity,” said José Reyes, the company’s co-founder and chief technology officer. Business Wire

The report is key as NuScale works to convert its reactor design into actual contracts. Securing industrial customers who need reliable steam and power would expand its market beyond utilities, offering investors a fresh metric to judge if the technology can hold its own on price.

This comes as investors continue to view nuclear developers as headline-sensitive plays. While a study isn’t a binding agreement, it has the power to recalibrate expectations about what a “first project” entails—and how large it should be.

NuScale teamed up with Oak Ridge National Laboratory for a two-year “techno-economic assessment” — a deep dive into cost and returns modeling. They ran scenarios mixing NuScale Power Modules, gas boilers, and hybrid setups, benchmarking against actual plant conditions and historical data. The study found a 12-module configuration to be the most profitable, thanks to its ability to sell surplus electricity to the grid. Meanwhile, a minimum four-module setup combined with boilers could cover the plant’s power needs, and an eight-module layout provided “N-2 redundancy,” meaning it could operate even if two modules went offline. nuscalepower.com

Before the market opened, NuScale stood out on Nasdaq’s premarket activity list, rising $0.14 to $20.65 with over 1.1 million shares changing hands.

NuScale is betting on small modular reactors — factory-built nuclear units designed to be deployed in multiples. But the sector’s history is riddled with delays and cost overruns. The U.S. Nuclear Regulatory Commission gave the green light to NuScale’s uprated 77-megawatt design in 2025, following earlier approval of a 50-megawatt version. Since scrapping its first U.S. project in 2023 due to rising costs, the company has been hunting for new customers.

The downside is clear: modeled economics can unravel if financing costs climb, build schedules delay, or customers hesitate over multi-year lead times. Even a promising industrial niche requires permits, partners, and funding — and those elements rarely line up neatly.

This week, traders are on the lookout for more than just modeling data from NuScale. According to the company’s investor calendar, key conference appearances are lined up: Monday at UBS’s winter energy and utilities event, then Needham’s growth conference on Jan. 15, and TD Securities’ winter summit on Jan. 26.

The company’s most recent quarterly update came in November, leaving investors eager for clearer guidance on commercialization costs and when customer commitments might materialize.

Stock Market Today

  • Steve Eisman short sells Fair Isaac amid favourable market view
    April 30, 2026, 11:17 AM EDT. Steve Eisman, known for 'The Big Short,' expresses confidence in the broader stock market while identifying select short-selling opportunities. Eisman specifically targets credit-scoring firm Fair Isaac (FICO), criticizing its steep price hikes of about 500%, which he says have alienated lenders and opened space for competitors like VantageScore. He highlighted that lenders pay approximately $2,000 per 100 mortgage applications to FICO versus $99 for VantageScore, signaling potential market share loss. Following the disclosure, FICO shares dropped 3.5%, continuing a nearly 40% decline in 2026. Eisman's portfolio remains weighted towards technology and financial stocks, steering clear of defensive sectors like staples and energy, reflecting his view of a resilient yet unevenly distributed economy.

Latest article

Altria Stock Jumps 7% After Marlboro Maker Beats Q1 Forecasts on Price Hikes

Altria Stock Jumps 7% After Marlboro Maker Beats Q1 Forecasts on Price Hikes

30 April 2026
Altria posted adjusted earnings of $1.32 per share and net revenues of $5.43 billion for the quarter, beating analyst estimates. Higher prices offset falling cigarette volumes, with domestic shipments down 2.4%. Shares rose about 7% in late-morning trading. CEO Billy Gifford is set to step down in mid-May.
Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

30 April 2026
Mastercard shares fell 2.7% Thursday despite first-quarter profit and revenue beating estimates, as investors reacted to slower April cross-border spending growth. Adjusted earnings reached $4.60 per share on $8.4 billion revenue. Cross-border volume growth dropped to 9% in April from 13% in Q1, with travel-linked growth at just 2%. Operating expenses rose 13%, including a $202 million restructuring charge.
Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

30 April 2026
Viavi Solutions shares surged about 20% in early U.S. trading after fiscal third-quarter revenue rose 42.8% to $406.8 million, beating estimates. Adjusted earnings reached 27 cents per share, above forecasts. The company projected fourth-quarter revenue of $427 million to $437 million. GAAP profit declined from a year earlier and cash flow was negative for the quarter.
CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom
Previous Story

CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

Why Recursion Pharmaceuticals (RXRX) stock is up today: a new JPM deck put cash runway back in focus
Next Story

Why Recursion Pharmaceuticals (RXRX) stock is up today: a new JPM deck put cash runway back in focus

Go toTop